Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2026-01-07 @ 9:23 PM
Study NCT ID:
NCT00072358
Status:
COMPLETED
Last Update Posted:
2022-05-16
First Post:
2003-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-07
Start Date Type:
None
Primary Completion Date:
2021-01-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-01-15
Completion Date Type:
ACTUAL
First Submit Date:
2003-11-04
First Submit QC Date:
None
Study First Post Date:
2003-11-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-01-14
Results First Submit QC Date:
None
Results First Post Date:
2022-05-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-21
Last Update Post Date:
2022-05-16
Last Update Post Date Type:
ACTUAL